Is Insider Buying at AdaptHealth (AHCO) Reframing the Story on Automation, Contracts, and Consolidation?

Simply Wall St.03-15

In recent days, AdaptHealth Corp. disclosed that major shareholder Richard M. Cashin Jr. purchased about 2,046,691 additional shares of the company’s common stock, lifting his reporting group’s stake ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2619017051?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","is_english":true,"pubTime":"2026-03-15 14:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619017051","market":"nz","top_or_hot":-1,"title":"Is Insider Buying at AdaptHealth (AHCO) Reframing the Story on Automation, Contracts, and Consolidation?","media":"Simply Wall St.","content":"<div>\n<p>In recent days, AdaptHealth Corp. disclosed that major shareholder Richard M. Cashin Jr. purchased about 2,046,691 additional shares of the company’s common stock, lifting his reporting group’s stake ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-insider-buying-at-adapthealth-ahco-reframing-the-story-on\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Insider Buying at AdaptHealth (AHCO) Reframing the Story on Automation, Contracts, and Consolidation?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Insider Buying at AdaptHealth (AHCO) Reframing the Story on Automation, Contracts, and Consolidation?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-15 14:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-insider-buying-at-adapthealth-ahco-reframing-the-story-on><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In recent days, AdaptHealth Corp. disclosed that major shareholder Richard M. Cashin Jr. purchased about 2,046,691 additional shares of the company’s common stock, lifting his reporting group’s stake ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-insider-buying-at-adapthealth-ahco-reframing-the-story-on\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4175","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-insider-buying-at-adapthealth-ahco-reframing-the-story-on","article_id":"2619017051","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-insider-buying-at-adapthealth-ahco-reframing-the-story-on","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2619017051","pubTimestamp":1773555802,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In recent days, AdaptHealth Corp. disclosed that major shareholder Richard M. Cashin Jr. purchased about 2,046,691 additional shares of the company’s common stock, lifting his reporting group’s stake to 15,864,871 shares in a transaction worth nearly US$20,000,000.\nThis sizeable insider purchase by a 10% owner comes shortly after AdaptHealth reported a quarterly earnings per share of US$0.76, which fell well short of expectations even as revenue slightly exceeded forecasts, drawing attention...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4175":"保健护理产品经销商","AHCO":"AdaptHealth Corp."},"translate_title":"AdaptHealth(AHCO)的内部收购是否正在重塑自动化、合同和整合的故事？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AHCO":1.5},"content_text":"In recent days, AdaptHealth Corp. disclosed that major shareholder Richard M. Cashin Jr. purchased about 2,046,691 additional shares of the company’s common stock, lifting his reporting group’s stake to 15,864,871 shares in a transaction worth nearly US$20,000,000. This sizeable insider purchase by a 10% owner comes shortly after AdaptHealth reported a quarterly earnings per share of US$0.76, which fell well short of expectations even as revenue slightly exceeded forecasts, drawing attention to how informed shareholders are reacting to the company’s current challenges. We’ll now consider how this substantial insider buying may influence AdaptHealth’s existing investment narrative built around long-term contracts, automation, and consolidation. Outshine the giants: these 19 early-stage AI stocks could fund your retirement.AdvertisementAdaptHealth Investment Narrative RecapTo own AdaptHealth, you need to believe that its long-term contracts, home-care focus, and automation can eventually outweigh current execution and reimbursement pressures. Cashin’s US$20,000,000 insider buy does not change the core near-term catalyst, which is delivering on the new US$1+ billion capitated contract without further margin strain. It also does not remove the biggest risk right now: potential pressure from CMS competitive bidding and payer negotiations that could squeeze already fragile profitability. The recent disclosure of a US$127,995,000 goodwill impairment tied to Q4 2025 is particularly relevant here. It underlines how past acquisitions and investments have already weighed on earnings at a time when the company is taking on additional infrastructure, acquisition spending, and a revolver draw to support expansion and its large capitated deal. Those same capital and integration demands sit right at the heart of the upcoming contract ramp that many investors are watching as a key catalyst. Yet while this insider buying may look reassuring, investors should be aware that the combination of goodwill write downs, thin margins, and CMS exposure means... Read the full narrative on AdaptHealth (it's free!)AdaptHealth's narrative projects $4.0 billion revenue and $157.7 million earnings by 2028.Uncover how AdaptHealth's forecasts yield a $13.12 fair value, a 24% upside to its current price.Exploring Other PerspectivesAHCO 1-Year Stock Price Chart Some of the lowest ranked analysts were already assuming only about 5.3 percent annual revenue growth to roughly US$3.8 billion and modest margin improvement, so their more cautious view on reimbursement and contract execution could look more relevant after this insider buying, reminding you that reasonable people can look at the same AdaptHealth story and reach very different conclusions.Explore 3 other fair value estimates on AdaptHealth - why the stock might be worth 19% less than the current price!Reach Your Own ConclusionDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your AdaptHealth research is our analysis highlighting 3 key rewards that could impact your investment decision.Our free AdaptHealth research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate AdaptHealth's overall financial health at a glance.Interested In Other Possibilities?Every day counts. These free picks are already gaining attention. See them before the crowd does:Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2619017051","isCrawlerRequest":true}